HIV/AIDS NDAs For Fixed-Dose Combination Will Be Exempt From User Fees

Expedited FDA review process for combination antiretroviral drugs announced at World Health Organization meeting. Generic versions of patented medicines would receive a “tentative” approval and be eligible for use in the Administration’s $15 bil. assistance program.